Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Allotment of 71800 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022 '.
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagsonpal Pharmaceuticals has allotted 71,800 equity shares to eligible employees under its Employee Stock Option Plan 2022, upon exercise of vested options. The shares were issued at an exercise price of Rs. 94 per share (Rs. 2 par value + Rs. 92 premium). As a result, the company's paid-up share capital rose from Rs. 13.38 crore to Rs. 13.39 crore, and total equity shares increased from 6,68,90,450 to 6,69,62,250. The newly issued shares will rank equally with existing shares in all respects, with no lock-in period.
This is a routine ESOP allotment with negligible dilution of about 0.01% of total shares, so it is largely neutral for existing shareholders. The exercise price of Rs. 94 brings in roughly Rs. 67.5 lakh of fresh capital, with no material effect on stock price or shareholding structure.